The Solution: Our Microbial Platforms
Our proprietary microbial platforms are uniquely positioned to address such challenges.
Over the past two decades Dyadic has developed a method for producing commercial quantities of enzymes and other proteins required for the production of industrial enzymes; and has successfully licensed this technology to third parties such as Abengoa Bioenergy, BASF, Codexis and others.